compounded semaglutide vomiting class action in louisiana Liraglutide vs Semaglutide vs GLP-1 semaglutide diarrhea Ozempic: Semaglutide is

Also known as LY3437943, retatrutide is a triple agonist that targets GLP-1, GIP and glucagon receptors

Dose timing and injection technique also matter

Weight loss and hormonal changes represent the most plausible explanation

For the full three-way comparison including semaglutide, see the GLP-1 comparison guide

This amplifies the many challenges associated with GLP-1s, like gastrointestinal side effects, nutrient inadequacies, muscle and bone loss, low long-term adherence, weight regain, and high costs

At 12 months, tirzepatide was associated with a greater mean weight loss of 14.7% compared to 10.8% for semaglutide